logo
UAE: Abu Dhabi expat survives cancer, opens green juicery to make ends meet

UAE: Abu Dhabi expat survives cancer, opens green juicery to make ends meet

Khaleej Timesa day ago
Ben Smith, a 27-year-old Abu Dhabi resident who grew up in the city, was just 22 when his life was interrupted when doctors diagnosed him with cancer in his appendix, shortly after graduating from university.
'It was the start of my life, really,' he said. 'All my friends were getting jobs, and I was thrown into the hospital.'
Over more than a year, Ben underwent treatments, surgeries, and long periods of waiting both in the UAE and the UK. He came out of the experience with no job, no clear plan, not much energy, but a new sense of clarity.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
'When you get cancer, nothing else matters. It puts you face-to-face with what's important, your health, your peace, your community.'
With little energy and no clear career path, Ben turned to a skill he had picked up during university while working part-time at Joe & The Juice. He began making juice at home for friends.
What started as a casual idea slowly grew into Pink and Greens, a health-conscious juicery that now operates with a strong environmental ethos and nearly zero packaging waste.
'I'm not a businessman,' Ben said. 'I'm more of a family man. I love the environment. I hate plastic. That's just me.'
The shop, located at an ADNOC station in Abu Dhabi, has developed organically with the help of a close-knit community.
At the core of Ben's business is the Earth Club, a glass bottle return system that encourages customers to bring back used bottles in exchange for a week's worth of free coffee.
'It's become a system that people actually follow,' he said. 'We've created a small loop of reuse, and it works.'
Challenges
Still, running an eco-conscious store comes with challenges. Paper cups, for example, don't show the colours or layers of the drinks, a key part of the visual appeal. The team is now transitioning to biodegradable cornstarch cups that look like plastic but break down naturally.
'We have to be careful that people don't misunderstand the material,' he said. 'It looks like plastic, but it's made from plants, and it goes back to the earth.'
Another challenge is managing the daily pulp generated from juicing fruits and vegetables. While Ben used to compost and deliver the pulp to local farms, he's now actively pursuing new ways to put it to use.
'I don't want it to go to waste,' he said. 'There's real potential in this pulp, and we're looking at how to make sure it stays a part of a sustainable cycle.'
'Everything felt more urgent'
Beyond juices, Ben has a wider goal in mind: reviving marine life in the UAE. In collaboration with a government-led initiative, Pink and Greens is planning to launch a bottled water line, where part of each purchase funds the planting of coral reef tiles made from 3D-printed terracotta. These tiles are placed on the seabed to support coral regeneration.
'When someone drinks water from us, they're also helping restore ocean life,' Ben said. 'That's the point, every product has a purpose. We're not just selling drinks. We're trying to make choices that give something back.'
Asked whether his interest in sustainability existed before his diagnosis,
'I always respected it. But after cancer, everything felt more urgent,' he said. 'It made me realise this is where I want my life to go, something that makes a real difference.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aster Clinics introduce Smyl AI – UAE's first AI Dental Tool
Aster Clinics introduce Smyl AI – UAE's first AI Dental Tool

Zawya

timean hour ago

  • Zawya

Aster Clinics introduce Smyl AI – UAE's first AI Dental Tool

Get free, instant dental screenings by answering a few simple questions and uploading three photos of your teeth (upper, lower, and front), all in under 2 minutes. Receive a detailed dental health report instantly. Easily schedule a consultation with Aster Clinic's 30+ expert dental specialists for personalized care. Dubai, UAE: In a major leap toward accessible and technology-driven oral healthcare, Aster Clinics, a leading integrated healthcare provider under Aster DM Healthcare in the GCC, has officially launched Smyl AI – the UAE's first AI-powered Dental Bot, designed to redefine how dental care is delivered and experienced. Smyl AI offers free, instant dental screenings via WhatsApp, making oral health assessments easier, faster, and more accessible than ever before. The launch of Smyl AI marks the beginning of Aster Clinics' Smarter Smiles initiative in the UAE - dedicated to enhancing awareness, enabling early detection, and promoting proactive dental care across the country. Developed in collaboration with India-based an expert in AI health technology, Smyl AI is the first solution of its kind to be introduced in the UAE dental landscape. The innovative AI-enabled tool empowers users to complete a dental screening in under 2 minutes by answering a few simple questions and uploading three images of their teeth (upper, lower, and front). The AI tool then generates a free dental health report, highlighting potential concerns such as cavities, gum disease, plaque, and stains. Users can then easily schedule a consultation with a dental specialist at their nearest Aster Clinic for further evaluation and care. Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics – UAE, Oman, and Bahrain, commented 'Artificial intelligence (AI) is playing an increasingly vital role in enhancing healthcare outcomes across various medical disciplines. Oral health is a window to overall well-being. Yet, many residents delay dental visits due to fear, cost, or inconvenience. At Aster We believe in moderate adjustments, without using the slogan of "disruptive changes", With Smyl AI, we are aiming to validate our existing processes and concepts and on the other hand automate quality and precision of care. Our goal is to integrate technology and care—making dental assessments not only more accurate but also more approachable for families, working professionals, and communities across the UAE.' A recent survey conducted on UAE residents revealed that 80% of participants suffer from dental caries, with 50% visiting a dentist only when in pain, and just 20% making annual dental visits. These alarming statistics highlight the pressing need for regular dental screening and education about oral hygiene. Poor oral hygiene, sugary diets, and low awareness continue to be key contributors. Other prevalent oral health issues include gum and periodontal diseases, plaque and tartar deposits, stains, and mouth sores, as indicated by the survey. Smyl AI is accessible via WhatsApp by visiting and starting a chat with 'Hi Aster Clinics.' From there, users can select their preferred language, input personal details, upload photos, and receive a comprehensive screening report—entirely free of cost. The tool instantly connects users with Aster Clinic's network of 30+ expert dental specialists for personalized treatment and trusted care. The tool ensures data privacy by complying with UAE healthcare information protection regulations and using secure, encrypted transmission protocols. All patient data is handled with utmost confidentiality and stored only with user consent. With a strong legacy of healthcare excellence, Aster's dental team offers professional advice, compassionate care, and reliable treatment outcomes you can trust. With a growing footprint of 110 Aster Clinics across the UAE, this first-of-its-kind initiative positions Aster Clinics as a pioneer in integrating AI into mainstream dental care. In line with the UAE's vision for improving healthcare access and awareness, Aster Clinics is committed to using innovative solutions like Smyl AI to drive positive changes in the oral health landscape. About Aster DM Healthcare FZC in GCC Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across 5 countries in the GCC and Jordan. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of 'We will treat you well'. The organisation's robust integrated healthcare model includes 15 hospitals, 122 clinics, and 313 pharmacies in GCC serving all segments of the society through three differentiated brands: Aster, Medcare and Access. Aster consistently adapts to meet the evolving needs of patients, ensuring access to quality healthcare through both physical and digital channels which is exemplified with the launch of the region's first healthcare super app, myAster.

Sheikh Shakhbout Medical City and AstraZeneca launch an asthma inhaler recycling initiative
Sheikh Shakhbout Medical City and AstraZeneca launch an asthma inhaler recycling initiative

Zawya

time3 hours ago

  • Zawya

Sheikh Shakhbout Medical City and AstraZeneca launch an asthma inhaler recycling initiative

Abu Dhabi, UAE: Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the UAE for serious and complex care and a subsidiary of the PureHealth group, has today announced its collaboration with global biopharmaceutical company AstraZeneca, to launch the 'Pure Air Solution' (PAS) initiative. This partnership, formalised through a Memorandum of Understanding (MoU), focuses on the recycling of asthma inhalers. While demonstrating a shared commitment to sustainable healthcare practices, this initiative also addresses the urgent need to reduce the healthcare sector's carbon footprint, which currently contributes to approximately 5% of the world's greenhouse gas (GHG) emissions. Commenting on the launch of the initiative, Dr. Marwan Al Kaabi, chief executive officer at SSMC, said: 'By implementing a comprehensive inhaler recycling programme, SSMC and AstraZeneca are taking a significant step towards mitigating environmental harm, which aligns with the UAE's vision for net-zero carbon emissions, by 2050.' Through the strategic placement of collection bins across SSMC's key clinics and pharmacies, the initiative will encourage asthma patients to participate in inhaler recycling. The partnership will also prioritise robust educational campaigns on asthma management and the importance of recycling – empowering both patients and staff at SSMC to engage in responsible disposal practices. Dr. Al Kaabi, added: 'The PAS initiative is further testament to SSMC's leadership in proactive environmental stewardship within the healthcare sector. By launching this programme, we are taking decisive strides towards a healthier, more sustainable future, while setting a precedent and establishing a benchmark for responsible healthcare practices, within the region.' Sameh El Fangary, cluster president for GCC and Pakistan at AstraZeneca, shared: 'Partnering with SSMC reflects our shared commitment to advancing innovative and sustainable respiratory care. This collaboration aims to reduce the environmental impact associated with inhaler use, aligning with our integrated approach to health—addressing both patient outcomes and environmental considerations.' Project leads Dr. Haytham Shahata, research clinical pharmacist, and Dr. Lubna Issa, drug store operations manager at SSMC, said: 'Inhalers, among the most prevalent medical devices used in the UAE, account for nearly 80% of inhaler-related GHG output.1 This is largely attributable to hydrofluorocarbon propellants, which are up to 2,500 times more potent than carbon dioxide and can remain in the atmosphere for over 200 years.2,3 With 96% of an inhaler's climate impact stemming from these potent emissions, the PAS initiative is designed to significantly minimise the carbon footprint of respiratory care.4' The PAS initiative reinforces the power of collaborative innovation in building a sustainable healthcare ecosystem. By fostering a culture of recycling and education, SSMC and AstraZeneca are taking the lead in advancing sustainable healthcare practices across the UAE, ultimately benefiting patients and the broader community by ensuring long-term health and environmental well-being. For media inquiries, please contact: Fadya Al Kathairi Sheikh Shakhbout Medical City Email: falkathairi@ Afaf El-Sharkawy 9Yards Communications Email: References Alzaabi A, Bell JP, Montero-Arias F, et al. Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study. Adv Ther. 2023;40(11):4836-4856. doi:10.1007/s12325-023-02663-2. Jeswani HK, Azapagic A. Life cycle environmental impacts of inhalers. J Clean Prod. 2019;237:117733. doi:10.1016/ Borgford-Parnell N, Beaugrand M, Andersen SO, Zaelke D. Phasing Down the Use of Hydrofluorocarbons (HFCs). Contrib Pap Seiz Glob Oppor Partnersh Better Growth Better Clim. New Clim Econ. 2015. PSNC Briefing 024.21. Reducing the climate change impact of inhalers: environmentally safe disposal. August 2021. About Sheikh Shakhbout Medical City (SSMC) Sheikh Shakhbout Medical City is one of the largest tertiary hospitals in the UAE offering the highest standards of medical expertise for the treatment of serious and complex conditions. Established in 2019, SSMC has 660 patient beds, 18 operating theatres, including a hybrid operating room and a 26-bed neonatal intensive care unit. Supported by the latest diagnostic and treatment modalities available, SSMC offers care in 46 specialties, bringing advanced and trusted quality care closer to the UAE and the wider region. For more information on Sheikh Shakhbout Medical City or to book an appointment, please visit: About PureHealth PureHealth is the largest healthcare group in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 100+ hospitals, 300+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, its groundbreaking innovations are at the forefront of healthcare as the company is on a mission to unlock time for humankind. By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world. PureHealth's network comprises: SEHA – One of the largest healthcare networks of hospitals and clinics in the UAE SEHA CLINICS - Delivering comprehensive community-based healthcare services Daman (The National Health Insurance Company) – The UAE's leading health insurer The Medical Office – Overseeing Sheikh Khalifa Hospitals and healthcare facilities established under the initiatives of H.H. The President of the UAE Rafed – The UAE's largest healthcare Group Purchasing Organisation PureLab – Managing and operating the largest network of laboratories in the region One Health – A network that provides end-to-end medical solutions to a base of over 300 healthcare service providers The Life Corner – Abu Dhabi's first holistic pharmacy, serving the health and wellness establishment Ardent Health Services – The fourth largest privately held acute care hospital operator in the US Circle Health Group – The largest independent operators of hospitals in the UK Hellenic Healthcare Group (HHG) - the largest private healthcare provider in Greece and Cyprus PureCS - A leading cloud and technology services provider, specialising in IT management and consulting solutions, cybersecurity, cloud services and AI information systems Sheikh Shakhbout Medical City (SSMC) – The UAE's largest healthcare complex, delivering integrated complex care To learn more, please visit

BioSapien extends Pre-series A funding round to over $8mln - with new investment from Globivest
BioSapien extends Pre-series A funding round to over $8mln - with new investment from Globivest

Zawya

time3 hours ago

  • Zawya

BioSapien extends Pre-series A funding round to over $8mln - with new investment from Globivest

New world-class talent for BioSapien also revealed: technological, operational, and medical excellence to shape future of precision medicine Abu Dhabi, U.A.E – BioSapien (the 'Company'), the pioneering biotech company behind MediChip™, a revolutionary localized cancer treatment platform - announces a new extension to its pre-Series A funding round and the appointment of new talent across the business - including Joseph Borrello PhD as Chief Technology Officer, Sonia Ramamoorthy MD MBA FACS as Head of Medical Affairs, Agnes Westelinck PharmD as Head of Regulatory U.S., Dirk Richter MD FACS as Head of Regulatory U.A.E., David Briere PhD as Director of Pharmacology, and Jerry Webb BSc as Head of Quality. BioSapien is delighted to welcome Globivest as an investor in the pre-Series A funding round. Globivest is the first women-led, gender lens venture capital fund from the MENA region - and has expertise in Life Sciences. BioSapien's pre-Series A funding total is now over $8 million, with investors including Global Ventures - a leading VC firm in MENA; plus Golden Gate Ventures and Dara Holdings. Globivest's stated mission is to break the myth that opposes capital returns to impact-driven models. Championing the WHO's 'One Health' approach, it specializes in innovative and scalable early-stage startups that drive health, social, and environmental change - making BioSapien an ideal fit for its portfolio. BioSapien also announces the acquisition of world-class talent across all tiers of the Company – with 12 new appointments. In addition to the appointments listed above, other new talent includes Zhiyu Xia PhD as Senior Manufacturing Engineer, Gaurav Vij MBA as Business Officer, Nancy Sperling MS MS as the QC Lead, Nivedita Sivakumar PharmD MS as Documentation and Compliance Manager, Manny Valenza BA as Clinical Development Associate and Jared Rice BA as the Research and Operations Lead. Dr. Khatija Ali, CEO of BioSapien, said: 'Two of the greatest challenges for young, fast-growing companies are establishing a strong balance sheet and attracting high-quality talent. Therefore, I am delighted to announce an extension of BioSapien's pre-Series A funding round. As a female-led healthcare fund in the MENA region - and backed by EU pharma - we are proud to have Globivest as an investor and strategic partner. 'Similarly, it gives me great pleasure to welcome new, world-class colleagues across all tiers of the Company. A business is only as good as its people - so it is thrilling to be joined by such high-quality, diverse talent. Together, we will shape a future where precision medicine is both globally impactful and locally accessible.' Dr. Laura-Joy Boulos, Partner at Globivest, commented: 'At Globivest, we back companies that don't just promise innovation - they deliver transformative, science-backed solutions with the power to shift paradigms. BioSapien's MediChip™ platform is a breakthrough in localized cancer treatment - scalable, precise, and deeply aligned with our One Health mission. We're proud to support Dr. Khatija Ali and her team as they build the future of accessible precision medicine.' Further information Thoburns Johanna Lawson-Dick BioSapien@ About BioSapien BioSapien is a clinical-stage biotechnology company pioneering the future of localized drug delivery through its proprietary biodegradable 3D-printed delivery platform. Headquartered between the United States and the UAE, BioSapien's flagship technology, MediChip™, enables sustained, targeted release of chemotherapeutics directly at the tumor site—minimizing systemic toxicity and revolutionizing cancer care. The company is backed by global experts in oncology, materials science, and regulatory strategy, and is preparing for its first-in-human clinical trials. As part of the UAE's growing biotech ecosystem, BioSapien is aligned with the nation's vision to advance precision medicine, health innovation, and localized manufacturing capabilities. With a clear regulatory pathway, strong IP portfolio, and transformational applications beyond oncology - including infectious disease and post-operative care - BioSapien is positioned to become a cornerstone of the UAE's sovereign biotech ambitions. For more information, visit About Globivest Globivest is the first women-led, gender-lens impact investment fund from the MENA region, championing the WHO's One Health approach. The fund blends financial returns with meaningful, science-backed impact, investing in tech-driven, early-stage startups at the intersection of health, social, and environmental innovation. With a footprint across EMEA and the Americas, Globivest supports cross-border scale and market expansion. A key differentiator lies in Globivest's partnership with Sci-dip, a digital health platform founded by Globivest partner Dr. Laura-Joy Boulos, connecting the fund to a network of over 10,000 PhD experts. This collaboration enhances scientific due diligence and positions Globivest as a trusted co-investor for top-tier VC firms — particularly in life sciences, where depth of domain expertise is essential. Managing partner Jasmine Busson is a Kauffman Fellow, joining a global network of elite investors responsible for over $8.5T in exits. With Fund II now officially closed and a growing portfolio of nine companies, Globivest is emerging as a leading force in science-driven impact investing in the region.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store